VRTX- Vertex Pharmaceuticals Incorporated

Name: Vertex Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 36 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kewalramani Reshma	133.5K	$60.29M	-
COO	Arbuckle Stuart A	63.4K	$28.62M	-
VP	Wagner Charles F Jr	51.1K	$23.07M	-
VP	Tatsis Ourania	42.3K	$19.10M	-
Other	Leiden Jeffrey M	24.0K	$10.85M	-

Activity

Buys and sells only

Transactions

10 filings · page 26

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 3, 2021	Arbuckle Stuart A	EVP, Chief Commercial Officer	Sale+OE	1,554	$213.74	$332,145.65	-0.4%	+0.2%	+13.7%
Feb 3, 2021	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	400	$216.56	$86,624.00	-0.2%	+0.2%	+13.7%
Nov 16, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sell	91	$223.53	$20,340.82	-0.1%	-	-
Nov 16, 2020	Sachdev Amit	EVP, Chief Patient Officer	Sell	42	$223.53	$9,388.24	-	-	-
Nov 16, 2020	Altshuler David48	EVP, Global Research And CSO	Sell	38	$223.47	$8,491.96	-	-	-
Nov 16, 2020	Arbuckle Stuart A	EVP, Chief Commercial Officer	Sell	7	$223.64	$1,565.49	-	-	-
Nov 10, 2020	Sachs Bruce I51	Director	Buy	15,000	$217.36	$3,260,465.00	+29.1%	-	-
Nov 4, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	2,330	$217.74	$507,328.80	-1.7%	-	-
Nov 3, 2020	Arbuckle Stuart A	EVP, Chief Commercial Officer	Sale+OE	1,553	$211.92	$329,115.22	-1.1%	-	-
Oct 5, 2020	Bhatia Sangeeta N.48	Director	Sale+OE	10,516	$266.79	$2,805,518.28	-13.1%	-	-

← PrevPage 26Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC